Cambridge UK: 27 July 2022
RSM UK has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs of One Nucleus Members, the Partner and One Nucleus in delivering on its core remit of supporting innovation.
Laragh Jeanroy, Managing Partner RSM East Anglia and Co-Head of Life Sciences at RSM commented
Author: Helen Baxter, Vice President, North Highland
I joined fellow Life Science enthusiasts at the OnHelix conference in Cambridge at the beginning of the month to listen and learn to some of the latest thinking in Innovation in the industry. A range of experts talked about BioInnovation in the pharma and biotech industry at the latest OnHelix conference in Cambridge July 2022. Here are some of the key themes that emerged from the conference.
Cambridge, 28th July 2022: Cambridge-based property developer and investor Howard Group is pleased to announce Sian Steele as its new Board Chair.
Sian will take up the position from 1st August after serving for the past two years as a Non-Executive Director of the Group.
Cpl Life Sciences UK is proud to have been part of the trailblazer groups for the first clinical research apprenticeships in industry – Clinical Trial Specialist degree apprenticeship (Level 6), and the Regulatory Affairs Specialist (Level 7) both launched in 2019. It is part of our ongoing work and commitment to ensure the worsening skills shortages in the UK life sciences sectors are addressed, through proactive initiatives and programmes to bring in new talent and upskill/reskill current workforces. We have always been passionate about ‘giving back’ and have dedic
One Nucleus Summer Life Sciences Dinner, Wednesday 6 July 2022
On the eve of our annual ON Helix Conference, we were pleased to welcome over 100 guests to attend the inaugural One Nucleus Summer Life Sciences Dinner on the stunning grounds of Babraham Research Campus.
The evening began with a networking drinks reception and once seated, Tony Jones, CEO, One Nucleus thanked the sponsors and guests for attending and supporting the evening.
Link below to EY blog by Pamela Spence (EY PArtner)
https://www.linkedin.com/pulse/how-you-prioritize-your-supply-chain-inve...
Invited guests enjoyed a look around Nottingham CRO Cellomatics Biosciences’ new lab facilities at Colwick Quays Business Park last week, at a special launch event hosted by the company’s CEO and founder, Dr Shailendra Singh.
Cellomatics moved into the purpose-built premises last month in the wake of rising demand for its bespoke preclinical and early drug discovery phase laboratory services. Representing a three-fold increase in the company’s footprint, the facility covers approximately 5,500 sq ft of space across two levels and allows rooms for further expansion.
AMSBIO has expanded its range of antibodies, biomarkers and assay kits related to free radicals (ROS and RNS), non-radical reactive derivatives (or oxidants) and antioxidants for researchers investigating the mechanism of oxidative stress.
It is widely recognized free radicals play a key role in physiological processes including protein phosphorylation as well as activation of transcriptional factors and immunity, but they need to be kept at a low level.
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services
Press release - Appointments
Macomics Announces New Hires as it Expands its Macrophage-based Drug Discovery and Operations Teams
Edinburgh and Cambridge, UK, 18 July 2022 - Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has made three new appointments to its scientific and operations teams, to support growth and accelerate its R&D.